Colon and rectal cancer Flashcards
Risk Factors for colon cancer
• Age >50 yrs
• High fat, low fiber diet
• IBS – Chronic ulcerative colitis and Crohn’s disease
• Familial adenomatous polyposis (FAP)
• Heriditary nonpolyposis colorecal cancer (HNPCC)
• Hamartomatous polyposis syndromes
• Peutz-Jeghers syndrome
• Juvenile polyposis
• Family history – Colorectal adenomas, Colorectal cancer
• Personal history of Colorectal adenomas, Ureterosigmoidostomy,
Breast, Ovarian and Uterine cancers
Lifestyle Factors associated with increased risk for Colorectal cancer
- Lack of physical activity
- Consumption of red meat
- Obesity
- Cigarette smoking
- Alcohol use
Lifestyle Factors associated with decreased risk for Colorectal cancer
• MVI containing folic acid • ASA and other NSAID’s • Post menopausal HRT • Ca supplementation • Selenium • Consumption of fruits, vegetables and fiber
Clinical Presentation of right sided colorectal cancers
Proximal (right sided) lesions present with symptoms caused by
anemia – fatigue, weight loss, shortness of breath, lightheadedness,
mahagony feces caused by occult bleeding
Clinical Presentation of left sided colorectal cancers
Distal (left sided) lesions present with symptoms of obstruction,
changes in BM pattern, postprandial colicky abdominal pain,
hematochezia
Most common CLINICAL MANIFESTATIONS of colorectal cancer
• Abdominal pain 44%
• Change in bowel habit 43%
• Hematochezia or melena 40%
• Weakness 20%
• Anemia without other gastrointestinal symptoms 11%
• Weight loss 6%
• Some patients have more than one abnormality
• 15 to 20% of patients have distant metastatic disease at the time of
presentation
What is the most common type of colorectal tutor?
Adenocarcinomas compromise >95% of all colorectal tumors
Colorectal tumor markers
Carcinoembryonic antigen (CEA)
Carbohydrate antigen (CA) 19 9, CA 50, and CA 195
• Have a low diagnostic ability to detect primary colorectal cancer,
overlap with benign disease
• low sensitivity for early stage disease
• An expert panel on tumor markers recommended that serum CEA levels not be used as a screening test for colorectal cancer
• Have prognostic utility
TNM Staging Classification of Colorectal Cancer: T stage
• TX - Primary tumor cannot be assessed
• T0 - No evidence of primary tumor
• Tis - Carcinoma in situ: intraepithelial or invasion of lamina propria
• T1 - Tumor invades submucosa
• T2 - Tumor invades muscularis propria
• T3 - Tumor invades through the muscularis propria into the subserosa or into
nonperitonealized pericolic or perirectal tissues
• T4 - Tumor directly invades other organs or structures, and/or perforates visceral
peritoneum
TNM Staging Classification of Colorectal Cancer: N stage
Regional lymph nodes (N)
• NX - Regional lymph nodes cannot be assessed
• N0 - No regional lymph-node metastasis
• N1 - Metastasis in 1 to 3 regional lymph nodes
• N2 - Metastasis in 4 or more regional lymph nodes
Prognosis and 5 yr survival rates for Colon Cancer
Ranges from 8 to 93% based on stage
- Stage I (T1-2N0) - 93%
- Stage IIA (T3N0) - 85%
- Stage IIB (T4N0) - 72%
- Stage IIIA (T1-2 N1) - 83%
- Stage IIIB (T3-4 N1) - 64%
- Stage IIIC (N2) - 44%
- Stage IV - 8%
Colorectal Cancer: Guidelines for screening average risk adults aged 50 years or older
- Fecal occult blood test (FOBT) every year
- Flexible sigmoidoscopy every five years
- FOBT every year combined with flexible sigmoidoscopy every five years.
- Double-contrast barium enema every five years
- Colonoscopy every ten years
Colorectal Cancer: Key elements in screening average risk people
- Symptoms require diagnostic work up
- Offer screening to men and women aged 50 and older
- Stratify patients by risk
- Options should be offered
- Follow up of positive screening test with diagnostic colonoscopy
- Appropriate and timely surgery for detected cancers
- Follow up surveillance required after polypectomy and surgery
- Providers need to be proficient
- Encourage participation of patients
Colorectal Cancer: Screening for high-risk people
Screening Guidelines differ for:
- A first-degree relative (sibling, parent, child) who has had colorectal cancer or an adenomatous polyp:
- Family history of FAP or
HNPCC
- Personal history of adenomatous polyps
- Personal history of colorectal cancer
- Personal history of inflammatory bowel disease
Colorectal Cancer: Differential diagnosis of malignant lesions
Adenocarcinoma Lymphoma Carcinoid tumor Kaposi’s sarcoma Prostate cancer